Literature DB >> 2167533

Cytomegalovirus hyperimmunoglobulin prophylaxis in the prevention of cytomegalovirus infection in immunosuppressed heart transplant patients.

M Havel1, H Teufelsbauer, A Laczkovics, R Kurz, E Wolner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167533

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  1 in total

1.  Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

Authors:  J M Aguado; M A Gomez-Sanchez; C Lumbreras; J Delgado; M Lizasoain; J R Otero; J J Rufilanchas; A R Noriega
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.